IN2014DN07839A - - Google Patents

Info

Publication number
IN2014DN07839A
IN2014DN07839A IN7839DEN2014A IN2014DN07839A IN 2014DN07839 A IN2014DN07839 A IN 2014DN07839A IN 7839DEN2014 A IN7839DEN2014 A IN 7839DEN2014A IN 2014DN07839 A IN2014DN07839 A IN 2014DN07839A
Authority
IN
India
Prior art keywords
intrauterine
formula
spirox
gynaecological
contraception
Prior art date
Application number
Inventor
Norbert Schmees
Lars Röse
Tuula Valo
Katja Prelle
Reinhard Nubbemeyer
Henriikka Korolainen
Harri Jukarainen
Original Assignee
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48142002&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2014DN07839(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG
Publication of IN2014DN07839A publication Critical patent/IN2014DN07839A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Reproductive Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention describes the intrauterine application of 18-methyl-15ß,16ß-methylene-19-nor-20-spirox-4-en- 3-one of the general formula (1) in contraception and gynaecological therapy, as well as an intrauterine System containing Compounds of formula (1).
IN7839DEN2014 2012-04-23 2013-04-19 IN2014DN07839A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102012206652 2012-04-23
PCT/EP2013/058220 WO2013160213A1 (en) 2012-04-23 2013-04-19 Intrauterine application of 18-methyl-15ss,16ss-methylene-19-nor-20-spirox-4-en-3-one systems, intrauterine systems containing 18-methyl-15ss,16ss-methylene-19-nor-20-spirox-4-en-3-one, as well as the use thereof in contraception and gynaecological therapy

Publications (1)

Publication Number Publication Date
IN2014DN07839A true IN2014DN07839A (en) 2015-04-24

Family

ID=48142002

Family Applications (1)

Application Number Title Priority Date Filing Date
IN7839DEN2014 IN2014DN07839A (en) 2012-04-23 2013-04-19

Country Status (28)

Country Link
US (1) US20150065472A1 (en)
EP (1) EP2841074A1 (en)
JP (1) JP2015514791A (en)
KR (1) KR20150004807A (en)
CN (1) CN104254333A (en)
AR (1) AR090799A1 (en)
AU (1) AU2013254840A1 (en)
BR (1) BR112014026193A2 (en)
CA (1) CA2871003A1 (en)
CL (1) CL2014002836A1 (en)
CO (1) CO7111255A2 (en)
CR (1) CR20140490A (en)
CU (1) CU20140121A7 (en)
DO (1) DOP2014000241A (en)
EA (1) EA201491922A1 (en)
EC (1) ECSP14024250A (en)
HK (1) HK1205000A1 (en)
IL (1) IL235095A0 (en)
IN (1) IN2014DN07839A (en)
MA (1) MA37444A1 (en)
MX (1) MX2014012849A (en)
PE (1) PE20142438A1 (en)
PH (1) PH12014502372A1 (en)
SG (1) SG11201406582XA (en)
TN (1) TN2014000444A1 (en)
TW (1) TW201350122A (en)
UY (1) UY34758A (en)
WO (1) WO2013160213A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015055789A1 (en) * 2013-10-17 2015-04-23 Bayer Pharma Aktiengesellschaft INTRAVAGINAL USE OF 18-METHYL-15ß,16ß-METHYLENE-19-NOR-20-SPIROX-4-EN-3-ONES, INTRAVAGINAL RINGS COMPRISING 18-METHYL-15ß,16ß-METHYLENE-19-NOR-20-SPIROX-4-EN-3-ONES, AND USE THEREOF IN CONTRACEPTION

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI90627C (en) 1992-07-31 1994-03-10 Leiras Oy Apparatus for providing a medicine rod with a jacket
PH30867A (en) 1992-07-31 1997-12-09 Leiras Oy Method and equipment for installing a medicine capsule on a support.
FI107339B (en) 1998-06-30 2001-07-13 Leiras Oy Drug-permeable membrane or matrix for drug delivery
US6056976A (en) 1998-11-12 2000-05-02 Leiras Oy Elastomer, its preparation and use
SK287719B6 (en) * 2000-01-18 2011-07-06 Bayer Schering Pharma Ag Drospirenone for hormone replacement therapy
CA2771944A1 (en) * 2003-07-16 2005-01-27 Teva Women's Health, Inc. Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
DE102006030416A1 (en) 2006-06-29 2008-01-03 Bayer Schering Pharma Ag 18-methyl-19-nor-androst-4-ene-17,17-spiroethers (18-methyl-19-nor-20-spirox-4-en-3-ones) and pharmaceutical compositions containing them
DE102007011105A1 (en) * 2007-03-02 2008-09-04 Bayer Schering Pharma Aktiengesellschaft Mineralcorticoid receptor antagonist for producing drug for permanent treatment of endometriosis, comprises spironolactone, eplerenone and drospirenone
DE102007063495A1 (en) * 2007-12-29 2009-09-17 Bayer Schering Pharma Aktiengesellschaft 19-nor-steroid derivatives having a 15α, 16α-methylene group and a saturated 17,17-spirolactone ring, their use and medicaments containing these derivatives
DE102007063496A1 (en) * 2007-12-29 2009-07-02 Bayer Schering Pharma Aktiengesellschaft 15,16-Methylene-17- (1'-propenyl) -17-3'-oxidoestra-4-en-3-one derivative, its use and the derivative-containing drug
EP2140860A1 (en) * 2008-07-03 2010-01-06 Bayer Schering Pharma Oy An improved method of contraception
WO2012063262A2 (en) * 2010-11-08 2012-05-18 Hll Lifecare Limited A novel intrauterine device with controlled copper release

Also Published As

Publication number Publication date
AU2013254840A1 (en) 2014-11-06
PH12014502372A1 (en) 2015-01-26
WO2013160213A1 (en) 2013-10-31
MX2014012849A (en) 2015-02-05
TN2014000444A1 (en) 2016-03-30
CO7111255A2 (en) 2014-11-10
CU20140121A7 (en) 2014-12-26
KR20150004807A (en) 2015-01-13
AR090799A1 (en) 2014-12-10
UY34758A (en) 2013-11-29
EA201491922A1 (en) 2015-04-30
MA37444A1 (en) 2016-11-30
TW201350122A (en) 2013-12-16
CR20140490A (en) 2014-11-17
SG11201406582XA (en) 2014-11-27
PE20142438A1 (en) 2015-02-01
ECSP14024250A (en) 2015-12-31
US20150065472A1 (en) 2015-03-05
CA2871003A1 (en) 2013-10-31
CN104254333A (en) 2014-12-31
IL235095A0 (en) 2014-12-31
HK1205000A1 (en) 2015-12-11
BR112014026193A2 (en) 2017-06-27
EP2841074A1 (en) 2015-03-04
JP2015514791A (en) 2015-05-21
CL2014002836A1 (en) 2015-03-13
DOP2014000241A (en) 2014-12-31

Similar Documents

Publication Publication Date Title
IN2015DN01156A (en)
PH12015501392A1 (en) Pesticidal compositions and processes related thereto
PH12014502397A1 (en) Pesticidal compositions and processes related thereto
EP4230264A3 (en) Prodrugs of fumarates and their use in treating various deseases
PH12015501394A1 (en) Pesticidal compositions and processes related thereto
PH12016501192A1 (en) Tetrahydropyridopyrazines modulators of gpr6
PH12015501393A1 (en) Pesticidal compositions and processes related thereto
PH12015502161A1 (en) Therapeutic compounds and compositions
PH12015501609A1 (en) Phenicol antibacterials
MX363347B (en) Salt of omecamtiv mecarbil and process for preparing salt.
PH12015501054A1 (en) Pyridiyloxyalkyl carboxamides and use thereof as endoparasiticides and nematicides
MX2016003725A (en) Compounds and their use for preparation of tau imaging agents and tau imaging formulations.
IN2015DN02109A (en)
UA117567C2 (en) Galactagogue compositions based on phosphatidylserine
MX365192B (en) Bendamustine derivatives and related compounds, and medical use thereof cancer therapy.
IN2014DN07839A (en)
MX2015014657A (en) Novel phenicol antibacterial agents.
IN2014KN02584A (en)
MX2017005669A (en) Benzylhydroxyde derivatives, preparation thereof and therapeutic use thereof.
PH12014502371A1 (en) Application of 18-methyl-15ss,16ss-methylene-19-nor-20-spirox-4-en-3-one systems in the treatment of menorrhagia, as well as intrauterine systems containing 18-methyl-15ss,16ss-methylene-19-nor-20-spirox-4-en-3-one for treating uterine bleeding disorders
IN2012DE00937A (en)
UA89388U (en) Use of glucosamine hydrochloride as agent protecting body from system exposure to high temperatures
UA91886U (en) 1-tert-butoxy-3-(2,2,6,6-tetramethyl-4-hydroxypiperidino)-2-propanol